ANGIOTENSIN-(1-7) AS A NOVEL THERAPEUTIC TARGET FOR RENAL CANCER.

$561,776FY2021Defense Health AgencyDOD

Beth Israel Deaconess Medical Center, Inc.

Investigators

View source on USAspending →

ANGIOTENSIN-(1-7) AS A NOVEL THERAPEUTIC TARGET FOR RENAL CANCER. · GrantIndex